FIELD: medicine.
SUBSTANCE: group of inventions concerns medicine, namely to the agents strengthening effect of processing by focused ultrasound of high intensity (HIFU). The agent, strengthening effect of HIFU processing, intended for HIFU-therapy, represents a substance which can reduce level of HIFU energy in a target site (EEF), containing the discrete phase consisting of a kernel, concluded in a capsule from a membrane-forming substance; and the continuous phase consisting of water medium, thus the discrete phase is homogeneously distributed in the continuous phase. The way of processing of a target site using the HIFU method consists in intravenous introduction of an effective dose of the specified strengthening agent by means of continuous and fast intravenous installation or bolus injection to the patient 0-168 hours prior to HIFU-therapy application. The way of an agent screening strengthening effect of HIFU processing, consists in HIFU-therapy application - to a concrete tissue, calculation of EEF(initial) energy, introduction of a strengthening agent-candidate in a biological tissue, measurement of EEF(experim.) energy, comparison of EEF(initial) and EEF(experim.), and in a choice of the strengthening agent-candidate concerning EEF(initial) to EEF(initial) it is more than 1. The given group of inventions allows reducing quantity of the acoustic energy necessary for damage of a target tissue, in unit of volume of a tissue in the course of HIFU processing, to reduce time of processing of target area and to improve therapeutic effects.
EFFECT: reduction of quantity of the acoustic energy necessary for damage of a target tissue, in unit of volume of a tissue in the course of HIFU processing, reduction of time of processing of target area and improvement of therapeutic effects.
19 cl, 24 ex, 10 tbl
Title | Year | Author | Number |
---|---|---|---|
STRENGTHENING AGENT FOR THERAPY WITH HIGH-INTENSIVE FOCUSED ULTRASOUND AND ITS APPLICATION | 2005 |
|
RU2359701C2 |
DISPERSE ACTIVATOR FOR HIGH-INTENSITY FOCUSED ULTRASONIC THERAPY AND ITS APPLICATION | 2005 |
|
RU2360700C2 |
FLUOCARBON EMULSION ACTIVATOR FOR HIGHLY INTENSIVE FOCUSED ULTRASOUND THERAPY AND ITS APPLICATION | 2005 |
|
RU2388492C2 |
EMBALOGENIC MATRIX DECOMPOSITION METHOD IN EXPERIMENT | 2020 |
|
RU2739669C1 |
METHOD OF EXPERIMENTAL ASSESSMENT OF THE THERAPEUTIC INFLUENCE OF FOCUSED ULTRASOUND ON VESSELS OF ANIMALS | 2016 |
|
RU2647481C1 |
METHOD OF COMBINED TREATMENT OF UNRESECTABLE CANCER OF EXTRAHEPINOUS BILE DUCTS | 2018 |
|
RU2703330C2 |
BIOCOMPATIBLE CONTRASTING AGENT, STABLE BIOCOMPATIBLE COLLOIDAL DISPERSION, METHOD OF PREPARING ULTRASONIC IMAGE OF ANIMAL, METHODS OF PREPARING CONTRASTING AGENT STABLE IN STORAGE | 1994 |
|
RU2131744C1 |
NONSPECIFIC IMMUNOTHERAPY AGENT | 2007 |
|
RU2341272C1 |
USE OF ICARITIN FOR OBTAINING MEDICINAL PRODUCTS | 2021 |
|
RU2806093C1 |
X-RAY CONTRASTING AGENT | 2005 |
|
RU2287346C2 |
Authors
Dates
2009-08-10—Published
2005-08-31—Filed